Wasdell makes multimillion-pound investment in new packaging equipment
The contract packaging company has plans to install new equipment for the company’s blister and bottle lines, vial labelling, stability chambers and cold storage capacity.
Wasdell Group, a pharmaceutical outsourcing partner, has confirmed it is making a multimillion-pound investment in new packaging equipment across its UK and Ireland sites.
The specialist in end-to-end supply chain service provider made the decision to invest in line with increasing demand for its manufacturing and packaging capabilities from its growing pharma and biotech client portfolio.
The investment, which is part of a long-term investment plan to expand the company's capacity and capabilities, includes equipment for the company’s blister and bottle lines, vial labelling, stability chambers and cold storage capacity.
The equipment will be installed across all Wasdell’s sites in the UK and Ireland, including the recently opened Dundalk facility.
In addition to meeting increased demand, Vincent Dunne, CEO at Wasdell, explained the company's new packaging equipment will "allow us to maintain the swift turnaround times and flexible service we are well known for in the industry".
According to Martin Tedham, Wasdell Group Chairman, the investment will also support the company's expanding customer base, particularly US life sciences companies that want to "source a provider that can readily navigate the European market and specialises in small-mid batch sizes.”
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance